You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

 

Online download statistics by month:

Online download statistics by month: October 2021 to July 2025

AbstractFullPdf
Oct 2021018825
Nov 20210808
Dec 20210488
Jan 202202811
Feb 20220133
Mar 20220175
Apr 202202112
May 202203416
Jun 20220349
Jul 20220253
Aug 20220418
Sep 20220228
Oct 202202212
Nov 20220158
Dec 20220114
Jan 20230159
Feb 20230344
Mar 20230146
Apr 20230136
May 202301910
Jun 2023071
Jul 20230107
Aug 2023043
Sep 20230100
Oct 20230104
Nov 20230143
Dec 20230225
Jan 20240187
Feb 20240167
Mar 2024012130
Apr 202401210
May 20240187
Jun 20240144
Jul 20240266
Aug 2024094
Sep 2024085
Oct 20240108
Nov 20240125
Dec 20240195
Jan 20250155
Feb 20250124
Mar 202501312
Apr 20250325
May 2025093
Jun 20250133
Jul 2025010
Total01040428